iRadimed IRMD Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $5.82M+24.1% | $6.44M+25.2% | $5.58M+10.4% | $5.77M+17.8% | $4.69M+13.3% | ||
| $455K+135% | $380.68K+95.0% | $383.72K+94.2% | $207.6K+4.3% | $194K-14.2% | ||
| $684K-17.2% | $696.24K+6.1% | $666.08K+5.7% | $730.68K+20.0% | $826K+31.4% | ||
| $8.29M+93.2% | $5.92M-1.1% | $6.99M-23.4% | $7.75M+16.7% | $4.29M+10.5% | ||
| $403K-89.1% | $294.17K-89.5% | $1.14M-70.1% | $2.64M+132% | $3.7M+1,266% | ||
| -$469K+88.0% | -$416.41K+86.4% | -$1.26M+68.5% | -$2.82M-122% | -$3.92M-718% | ||
| $2.56M+18.2% | $8.55M+350% | $2.16M+13.8% | $2.16M+13.8% | $2.16M-72.9% | ||
| -$2.61M-14.4% | -$10.87M-350% | -$2.19M-14.3% | -$2.26M-15.2% | -$2.28M+71.7% | ||
| $5.22M+374% | -$5.37M-1,146% | $3.53M+10.8% | $2.66M-21.8% | -$1.9M+58.9% | ||
| $7.89M+1,226% | $5.63M+76.1% | $5.85M+10.2% | $5.11M-7.2% | $595K-83.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does iRadimed generate?
- iRadimed (IRMD) generated $28.9M in operating cash flow over the trailing twelve months.
- What is iRadimed's free cash flow?
- After $4.5M of capital expenditures, iRadimed's free cash flow was $24.5M over the trailing twelve months, up 67.6% year over year.
- Where does iRadimed's cash flow data come from?
- Every line is extracted from iRadimed's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
